E
Enable Medicine
About Enable Medicine
Enable Medicine is a technology startup that operates in the healthcare and biotechnology sector. The company has developed a cloud-based platform that facilitates the generation, management, and analysis of spatial biology data. This platform is designed to accelerate the discovery of insights in the field of biology, particularly in the area of cancer research.
Read full description
The company's primary clients are researchers and bioinformatics software developers. For researchers, Enable Medicine provides a platform that simplifies and accelerates the process of conducting experiments and analyzing data. For software developers, the company offers toolkits that allow them to build and deploy their applications on the Enable Cloud Platform.
Enable Medicine operates in a niche market, focusing on the intersection of biology and technology. The company's business model revolves around providing a cloud-based platform and tools that facilitate biological research. The company generates revenue by charging users for access to its platform and tools.
The company's platform, known as the Enable Cloud Platform, includes two main components: BIOS and Atlas. BIOS provides a suite of no-code applications and data science environments that streamline spatial biology workflows. Atlas, on the other hand, is a cloud database that centralizes and indexes biological data, making it easy to search and utilize.
In summary, Enable Medicine is a biotech startup that provides a cloud-based platform for generating, managing, and analyzing spatial biology data. The company serves researchers and software developers, operating in a niche market at the intersection of biology and technology.
At a glance
- Status
- Acquired
- Founded
- 2019
- Headquarters
- Menlo Park, United States
- Employees
- 16
- Open positions
- 1
- Dealroom signal
- 61.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Enable Medicine.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Dec 2024 | $0 | — | General Inception | ↗ |
| SERIES AOther financing | Jan 2022 | $60M | $240M | General Catalyst · Presight Capital · Axial VC · Initialized Capital | ↗ |
Growth signals
Latest recorded traffic for Enable Medicine is 11K monthly website visits, down 8.3% over the last three months. Enable Medicine's team declined 5.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
General Catalyst
Presight Capital
Axial VC
Initialized Capital
Anthos Capital
Breyer Capital
Other known investors1 additional known investor
General Inception
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enable Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enable Medicine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.